Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
The highest doses studied 8 mg and 12 mg were associated with the greatest weight loss outcomes in trial data, but also with a higher incidence of side effects
Retatrutide is an advanced investigational peptide known for its triple hormone receptor activity, targeting
Patients seeking GLP-1 therapy should consult healthcare providers about FDA-approved options
While GLP-1 medications have been approved as treatments for children with type 2 diabetes since 2019, pediatric prescriptions spiked after Wegovys high-profile FDA approval for adolescents in December 2022, which specified that it can be used for weight loss
[See Adverse Reactions.] Macrovascular Outcomes There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Janumet or any other anti-diabetic drug
No statement should be taken as healthcare advice
US$ 28.97
US$ 21.70
US$ 22.01
US$ 25.25
US$ 26.43
US$ 22.01
US$ 22.59
US$ 23.81
US$ 27.34
US$ 21.90
